Filter Results
:
(276)
Show Results For
-
All HBS Web
(115,838)
- Faculty Publications (276)
Show Results For
-
All HBS Web
(115,838)
- Faculty Publications (276)
- September 2023 (Revised March 2024)
- Teaching Note
On
By: Ramon Casadesus-Masanell, Karolin Frankenberger, Sascha Mader and Jordan Mitchell
Teaching Note for HBS Case No. 723-430.
View Details
- September 2023
- Supplement
On - Instructor Version
By: Ramon Casadesus-Masanell, Karolin Frankenberger, Sascha Mader and Jordan Mitchell
- September 2023
- Supplement
On - Student Version
By: Ramon Casadesus-Masanell, Karolin Frankenberger, Sascha Mader and Jordan Mitchell
- August 2023 (Revised April 2024)
- Case
eBee: Affordable Mobility for Africa
By: Ramon Casadesus-Masanell and Gamze Yucaoglu
The case opens in March 2023, as Sten van der Ham and Jaap Maljers, CEO and co-founder of eBee, an electric bike (e-bike) company in Africa, are contemplating the different avenues for growth and path to profitability for the young and ambitious company. In 2023, the...
View Details
Casadesus-Masanell, Ramon, and Gamze Yucaoglu. "eBee: Affordable Mobility for Africa." Harvard Business School Case 724-360, August 2023. (Revised April 2024.)
- August 2023
- Supplement
Zurich Insurance (A)
By: Ramon Casadesus-Masanell, Stefano Brusoni, Claudio Feser, Karolin Frankenberger and Ana Procopio Schoen
- August 2023
- Supplement
Zurich Insurance (B)
By: Ramon Casadesus-Masanell, Stefano Brusoni, Claudio Freser, Karolin Frankenberger and Ana Procopio Schoen
- August 2023
- Supplement
Airbus vs. Boeing (G)-(O)
By: Ramon Casadesus-Masanell, Karen Elterman and Jordan Mitchell
- August 2023
- Supplement
Airbus vs. Boeing (N): Air Travel amidst COVID-19 (July 2020)
By: Ramon Casadesus-Masanell and Jordan Mitchell
Casadesus-Masanell, Ramon, and Jordan Mitchell. "Airbus vs. Boeing (N): Air Travel amidst COVID-19 (July 2020)." Harvard Business School Supplement 724-377, August 2023.
- August 2023
- Supplement
Airbus vs. Boeing (O): Aiming towards Carbon-Free Flying (June 2023)
By: Ramon Casadesus-Masanell and Jordan Mitchell
Casadesus-Masanell, Ramon, and Jordan Mitchell. "Airbus vs. Boeing (O): Aiming towards Carbon-Free Flying (June 2023)." Harvard Business School Supplement 724-378, August 2023.
- August 2023
- Supplement
Zurich Insurance (C): Re-establishing a Leading Market Position in Retail
By: Ramon Casadesus-Masanell, Stefano Brusoni, Claudio Freser, Karolin Frankenberger and Ana Procopio Schoen
- August 2023
- Supplement
Zurich Insurance (B): Re-establishing a Leading Market Position in Retail
By: Ramon Casadesus-Masanell, Stefano Brusoni, Claudio Freser, Karolin Frankenberger and Ana Procopio Schoen
- July 2023 (Revised April 2024)
- Case
Zurich Insurance (A): Re-establishing a Leading Market Position in Retail
By: Ramon Casadesus-Masanell, Stefano Brusoni, Claudio Feser, Karolin Frankenberger and Ana Procopio Schoen
Casadesus-Masanell, Ramon, Stefano Brusoni, Claudio Feser, Karolin Frankenberger, and Ana Procopio Schoen. "Zurich Insurance (A): Re-establishing a Leading Market Position in Retail." Harvard Business School Case 724-362, July 2023. (Revised April 2024.)
- June 2023
- Teaching Note
Keroche (A)–(F)
By: Ramon Casadesus-Masanell and Namrata Arora
Teaching Note for HBS Case Nos. 720-390, 720-391, 720-392, 720-393, 720-394, and 720-395.
View Details
- June 2023
- Teaching Note
Oriental Land Co., Ltd. — Tokyo Disney Resort
By: Ramon Casadesus-Masanell and Akiko Kanno
Teaching Note for HBS Case No. 720-460.
View Details
- May 2023 (Revised June 2023)
- Case
Novartis (A): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,...
View Details
Keywords:
Health Care and Treatment;
Business Model;
Leadership;
Pharmaceutical Industry;
Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (A): Reimagining Medicine." Harvard Business School Case 723-443, May 2023. (Revised June 2023.)
- May 2023 (Revised June 2023)
- Supplement
Novartis (B): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,...
View Details
Keywords:
Health Care and Treatment;
Business Model;
Production;
Business Strategy;
Pharmaceutical Industry
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (B): Reimagining Medicine." Harvard Business School Supplement 723-444, May 2023. (Revised June 2023.)
- May 2023 (Revised June 2023)
- Supplement
Novartis (C): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,...
View Details
Keywords:
Health Testing and Trials;
Health Care and Treatment;
Business Model;
Problems and Challenges;
Pharmaceutical Industry;
Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (C): Reimagining Medicine." Harvard Business School Supplement 723-445, May 2023. (Revised June 2023.)